Home
 
 
About Hypertension
 
 
About MICARDIS®
 
 
Managing Blood Pressure
 
 
FAQs
 
 
Tools and Resources
 

Questions to ask your doctor

Blood pressure tracking record

Food and exercise journal

Other sites
 
E-Mail Options
 

Questions to ask your doctor

Prescribing Information
Contact Us
Site Map
  • What is high blood pressure?
  • Is there a cure for high blood pressure?
  • What is "normal" blood pressure?
  • What causes high blood pressure?
  • What can I do to help lower my blood pressure?
  • Are there medications to help control my blood pressure?
  • What is MICARDIS?
  • Are there any side effects associated with MICARDIS?

If you would like to print these questions so you can take them to your doctor, click here.

Selected important cautionary information
MICARDIS (telmisartan) Tablets is contraindicated in patients who are hypersensitive to any component of this product.
MICARDIS HCT (telmisartan/hydrochlorothiazide) is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.
When pregnancy is detected, MICARDIS and MICARDIS HCT Tablets should be discontinued as soon as possible (see WARNINGS, Fetal/Neonatal Morbidity and Mortality).

In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted (e.g., those receiving high doses of diuretics), symptomatic hypotension may occur after initiation of MICARDIS or MICARDIS HCT therapy. This condition should be corrected prior to administration of MICARDIS or MICARDIS HCT, and treatment should start under close medical supervision.

Patients with biliary obstructive disorders or hepatic insufficiency should have treatment started under close medical supervision.

The most common adverse events occurring in ≥2% of patients taking MICARDIS HCT vs placebo, respectively, were: dizziness (5%, 1%), diarrhea (3%, 0%), fatigue (3%, 1%), nausea (2%, 0%), influenza-like symptoms (2%, 1%), sinusitis (4%, 3%), and URTI (8%, 7%).